Prostate-Specific Antigen Density (PSAD)

ورودی‌های بالینی بیمار

حداقل ۰.۱ — حداکثر ۱۰۰۰ • واحد: ng/mL

حداقل ۵ — حداکثر ۳۰۰ • واحد: cc

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
psa density
—ng/mL/cc
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low0–0.15
  • Elevated0.15–100
Direct Clinical Answer

The Prostate-Specific Antigen Density (PSAD) calculates evaluating lower urinary tract symptoms, nephrolithiasis burden, and prostate cancer risk. Key inputs include psa. Scores guide initiating medical expulsive or alpha-blocker therapy, ordering renal imaging, or scheduling surgical intervention. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

PSA divided by prostate volume; >= 0.15 ng/mL/cc raises suspicion for prostate cancer.

Clinical Indication

The Prostate-Specific Antigen Density (PSAD) is indicated for bedside clinical practice to support PSA divided by prostate volume; >= 0.15 ng/mL/cc raises suspicion for prostate cancer.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with renal colic, hematuria, benign prostatic hyperplasia (BPH), or urogenital malignancies. Clinical application is indicated across Urology clinics, shock wave lithotripsy suites, and acute urologic surgical services.

Limitations & Contraindications

Serum PSA levels can be transiently elevated by acute prostatitis, urinary retention, or recent instrumentation.

Clinical Pearls & Action Plan

Obstructive urolithiasis complicated by upper urinary tract infection represents a surgical emergency requiring urgent decompression.

Formula & Variables:

PSAD = PSA (ng/mL) / prostate volume (cc)

Input Parameters

NameTypeRequiredDescription
psafloatYesTotal PSA(ng/mL)
prostate_volumefloatYesProstate volume (TRUS/MRI)(cc)

Score Interpretation & Guidance

RangeStageDescription
0–0.15LowPSAD below 0.15
0.15–100ElevatedPSAD 0.15 or higher

Evidence-Based References (EBM)

  • Benson MC, Whang IS, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 1992;147(3 Pt 2):815-816.

Related calculators